BTW
CELG

Boston Trust Walden’s Celgene Corp CELG Stock Holding History

Boston Trust Walden’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-5,121
Closed -$509K – 388
2019
Q3 		$509K Sell
5,121
-180
-3% -$17.1K 0.01% 324
2019
Q2 		$490K Sell
5,301
-200
-4% -$19K 0.01% 331
2019
Q1 		$519K Hold
5,501
– – 0.01% 329
2018
Q4 		$353K Hold
5,501
– – 0.01% 342
2018
Q3 		$492K Buy
5,501
+100
+2% +$8.84K 0.01% 332
2018
Q2 		$429K Buy
5,401
+180
+3% +$14.9K 0.01% 340
2018
Q1 		$466K Sell
5,221
-669
-11% -$64.2K 0.01% 339
2017
Q4 		$615K Sell
5,890
-1,000
-15% -$113K 0.01% 327
2017
Q3 		$1M Sell
6,890
-1,702
-20% -$232K 0.02% 305
2017
Q2 		$1.12M Buy
8,592
+2,396
+39% +$294K 0.02% 294
2017
Q1 		$771K Sell
6,196
-369
-6% -$44.2K 0.01% 300
2016
Q4 		$760K Sell
6,565
-332
-5% -$37K 0.01% 303
2016
Q3 		$721K Sell
6,897
-400
-5% -$43.3K 0.01% 302
2016
Q2 		$720K Buy
7,297
+266
+4% +$27.5K 0.01% 303
2016
Q1 		$704K Sell
7,031
-81
-1% -$8.34K 0.01% 306
2015
Q4 		$852K Sell
7,112
-629
-8% -$72.8K 0.02% 292
2015
Q3 		$837K Sell
7,741
-1,279
-14% -$159K 0.01% 296
2015
Q2 		$1.04M Hold
9,020
– – 0.02% 285
2015
Q1 		$1.04M Buy
9,020
+3,220
+56% +$385K 0.02% 280
2014
Q4 		$649K Hold
5,800
– – 0.01% 303
2014
Q3 		$550K Hold
5,800
– – 0.01% 304
2014
Q2 		$498K Sell
5,800
-1,400
-19% -$106K 0.01% 301
2014
Q1 		$503K Hold
7,200
– – 0.01% 283
2013
Q4 		$608K Hold
7,200
– – 0.01% 284
2013
Q3 		$555K Hold
7,200
– – 0.01% 277
2013
Q2 		$421K Buy
+7,200
New +$433K 0.01% 278

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $6.11B AUM 33.56% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $420M AUM 14.29% 1-Year Est. Return

Boston Trust Walden's CELG Position: Q4 2019 in Review

Boston Trust Walden sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 5,121 shares — an estimated $509K sold.

Boston Trust Walden first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $1.12M in Q2 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Boston Trust Walden reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Boston Trust Walden sold 5,121 Celgene Corp shares in Q4 2019, an estimated $509K.
  • Boston Trust Walden first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Boston Trust Walden's Celgene Corp position peaked at $1.12M in Q2 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Boston Trust Walden's 13F filing for Q4 2019, filed 10 Jan 2020.